HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY
Technology
E-065-2017
Patent ID
E-065-2017-0-EP-05
Country
EP
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
3625256
Application Number
18727536.7
IC
NCI
Date Filed
Date Issued
Patent PDF